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Abstract ADP ribosylation factors (ARFs) are critical in the
vesicular trafficking pathway. ARF activity is controlled by
GTPase-activating proteins (GAPs). We have identified recently
a novel tentative ARF GAP derived from human fetal liver,
ARFGAP3 (originally named as ARFGAP1). In the present
study, we demonstrated that ARFGAP3 had GAP activity in
vitro and remarked that the GAP activity of ARFGAP3 was
regulated by phospholipids, i.e. phosphatidylinositol 4,5-diphos-
phate as agonist and phosphatidylcholine as antagonist. ARF-
GAP3 is a predominantly cytosolic protein, and concentrated in
the perinuclear region. Its transient ectopic overexpression in
cultured mammalian cells reduced the constitutive secretion of
secreted alkaline phosphatase, indicating that ectopic over-
expression of ARFGAP3 inhibits the early secretory pathway
of proteins in vivo. These results demonstrated that ARFGAP3 is
a novel GAP for ARF1 and might be involved in intracellular
traffic of proteins and vesicular transport as predicted. ß 2001
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
In eukaryotic cells, the transport of materials between intra-
cellular compartments is mediated by transporting vesicles
that bud from a donor membrane and subsequently fuse
with an acceptor compartment [1]. ADP ribosylation factors
(ARFs), members of the Ras superfamily of GTP-binding
proteins, play critical roles in vesicular tra⁄cking [2^4]. Like
Ras, ARFs are active in their GTP-bound form, and their
duration of activity is controlled by GTPase-activating pro-
teins (GAPs). GTP hydrolysis, in which an ARF GAP is in-
volved, is required for the dissociation of coat proteins from
Golgi-derived membranes and vesicles [5,6], and the dissocia-
tion of coat proteins is a prerequisite for the vesicle’s fusion
with target compartment. Some proteins with ARF GAP ac-
tivity or ARFGAP-like motif have been identi¢ed, including
Rattus norvegicus ARF1 GAP [7,8], Saccharomyces cerevisiae
Gcs1 [9], Mus musculus ASAP1 [10], R. norvegicus GIT1 [11],
R. norvegicus Pap [12], and S. cerevisiae Glo3 [13]. Moreover,
the crystal structural and functional analysis of the complex
of human ARF1 with rat ARF1 GAP was reported recently
[14]. However, the knowledge about the complexity and im-
portance of ARF GAP-directed vesicle transport, especially
those from human, is still limited.
Recently, we have identi¢ed a novel human ARFGAP,
ARFGAP3 (originally named as ARFGAP1) [15]. ARFGAP3
encodes a polypeptide of 516 amino acids with an ARF GAP
domain that is required for ARF1 GAP catalytic functions
[16,17]. Like other members of ARF GAP family, ARFGAP3
contains a distinctive GATA-1-type zinc ¢nger motif
(CX2CX16CX2C). It is highly expressed in endocrine glands
and testis. Although ARFGAP3 might play a role in regula-
tion of cellular secretion, its function was not characterized
yet. Here we report that ARFGAP3 did have ARFGAP ac-
tivity in vitro. Remarkably, the GAP activity of ARFGAP3
could be regulated by phospholipids. We also provide evi-
dence that ARFGAP3 inhibits the constitutive secretion of
secreted alkaline phosphatase (SEAP) in vivo.
2. Materials and methods
2.1. Reagents
pEGFP-C1, mouse monoclonal anti-GFP antibody, and Great Es-
cAPe1 SEAP chemiluminescence detection kit were purchased from
Clontech; the pBAD/TOPO0 Thio-Fusion1 expression system,
Xpress1 system protein puri¢cation kit, EnterokinaseMax1 kit,
EK-away kit, pcDNA3.1/myc-His A, mouse monoclonal anti-myc-
HRP antibody from Invitrogen; arabinose, L-K-dimyristoyl phospha-
tidylcholine (DMPC), sodium cholate, creatine phosphokinase, phos-
phatidylcholine (PC), phosphatidylinositol 4,5-diphosphate (PIP2),
and polyethyleneimine^cellulose plates from Sigma; DMEM, and fe-
tal bovine serum from Life Technologies; restriction enzymes, unless
otherwise indicated, from Promega. Recombinant, myristoylated
ARF1 was prepared from bacteria co-expressing ARF1 and N-myr-
istoltransferase, which was kindly provided by Dr. Dan Cassel [8,18].
pGEM-SEAP was kindly provided by Dr. Monier [19].
2.2. Construction of expression vector of ARFGAP3
For mammalian fusion expression with GFP, the coding region of
ARFGAP3 was generated by PCR from pGEM-T-ARFGAP3 [15]
with the forward primer 5P-CGGAATTCGATGGGGGACCCCAG-
CAAGCA-3P (italicized sequence, EcoRI site) and reverse primer
5P-CGGGATCCAGAACCGTAGCGATCCTGAA-3P (italicized se-
quence, BamHI site). The PCR product after digestion with EcoRI
and BamHI was extracted and puri¢ed from low-melting (LM) aga-
rose gel, and ligated in-frame to the EcoRI- and BamHI-digested
pEGFP-C1 expression vector. The subcloned sequence of the ARF-
GAP3 was con¢rmed by automated sequencing on an ABI Prism 377-
XL DNA sequencer (Perkin-Elmer) in both forward and reverse di-
rection using EGFP-C1 sequencing primers (Clontech).
For expression of the recombinant ARFGAP3 as a fusion protein
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with thioredoxin in Escherichia coli, the coding region of ARFGAP3
was generated by PCR from pGEM-T-ARFGAP3 [15] with the for-
ward primer 5P-GGGATCCCGATGGGGGACCCCAGC-3P (itali-
cized sequence, BamHI site) and reverse primer 5P-CTCGAGAGA-
ACCGTAGCGATCCTG-3P (italicized sequence, XhoI site). The
PCR product was extracted and puri¢ed from LM agarose gel, and
ligated in-frame to the pBAD/Thio-TOPO bacterial fusion expression
vector with thioredoxin and a 6UHis tag sequence.
For mammalian expression, the coding region of ARFGAP3 was
obtained by digesting pBAD/thio^ARFGAP3 with BamHI and XhoI,
extracted and puri¢ed from LM agarose gel, and ligated in-frame to
the BamHI- and XhoI-digested pcDNA3.1/myc-hisA expression vector
(Invitrogen).
2.3. Expression and puri¢cation of the recombinant ARFGAP3 in
bacteria
The thioredoxin^ARFGAP3 fusion protein was expressed in E. coli
TOP10 induced by arabinose, and puri¢ed by a⁄nity chromatography
on a nickel-chelating column (Invitrogen) and cleaved by enterokinase
(Invitrogen). Enterokinase was excluded by using EKaway kit (Invi-
trogen), and then ARFGAP3 was puri¢ed again on a nickel-chelating
column according to the manufacturer’s instructions.
2.4. Cell culture and transient transfection
COS-7 cells were plated into 6-well trays (6U35 mm) at a density of
2U105 cells per well and grown in complete medium that consisted of
Dulbecco’s modi¢ed Eagle medium (DMEM) with 10% fetal calf se-
rum, 2 mM glutamine at 37‡C in a 5% CO2 incubator. The cells were
transfected at the next day with 5 Wg of plasmid DNAs together with
10 Wl lipofectamine (Life Technologies) according to the manufactur-
er’s instructions. Plasmid DNAs (5 Wg) and lipofectamine (10 Wl) were
diluted separately with DMEM without serum and antibiotics, and
combined (1 ml in ¢nal volume) just before applying to cells (80%
con£uent). After 6V12 h of incubation at 37‡C, 2 ml of culture
medium with fetal bovine serum was added. Expression of ARFGAP3
was assessed by Western blotting analysis 48 h after transfection,
except in the time-course experiment.
2.5. Subcellular localization of ARFGAP3 by £uorescence labeling
Live cells for epi£uorescence microscopy were plated into 6-well
trays (6U35 mm) at a density of 2U105 cells per well and transfected
with plasmid pEGFP-C1-ARFGAP3 at the next day. Cells were ex-
amined 12^48 h after transfection with a Zeiss Axioscope epi£uores-
cence microscope equipped with a Princeton Instruments cooled CCD
camera with MetaMorph digital imaging software (Universal Imag-
ing). The expression of pEGFP-C1-ARFGAP3 was veri¢ed by immu-
noblotting analysis.
2.6. Immunoblotting analysis
For immunoblotting analysis, cells were washed with ice-cold phos-
phate-bu¡ered saline (PBS) and lysed in 50 mM HEPES (pH 7.2), 150
mM NaCl, 1 mM EDTA, 10% glycerol, 1% Triton X-100, 1 mM
sodium orthovanadate, 40 mM L-glycerophosphate, 10 mM sodium
pyrophosphate, 1 mM phenylmethyl sulfonyl £uoride (PMSF), 10 Wg/
ml of leupeptin, and 10 Wg/ml of aprotinin (lysis bu¡er). Total cell
lysates from transfected COS-7 cells were pre-cleared by centrifuga-
tion, separated by sodium dodecyl sulfate^polyacrylamide gel electro-
phoresis (SDS^PAGE) and transferred to nitrocellulose by conven-
tional techniques. Filters were blocked overnight with TBS bu¡er
containing 5% dry milk at 4‡C and incubated with the mixture of
antibodies and TBS bu¡er containing 5% dry milk; then washed by
TBS bu¡er containing 0.05% Tween 20 and stained by ECL Western
blotting detection system according to the manufacturer’s instruc-
tions.
2.7. GAP activity assay of ARFGAP3
ARF GAP activity was determined by an in vitro assay that mea-
sures a single round of GTP hydrolysis on recombinant ARF1 [20,21].
ARF1 was ¢rst loaded with [K-32P]GTP as described [22]. DMPC and
cholate was used to facilitate the loading of ARF1 with GTP [8]. The
loading reaction mixture contained ARF1 (0.5 mg/ml), [K-32P]GTP
(0.2 mCi/ml, 0.25 WM, 5 mM MgCl2, 1 mM DTT, 1 mM ATP plus
ATP/GTP regeneration system (5 mM phosphocreatine and 50 Wg/ml
creatine phosphokinase), 25 mM MOPS bu¡er (pH 7.5), 150 mM
KCl, and a mixture of DMPC and sodium cholate added last from
a 10Ustock to give 3 mM and 1 mg/ml respectively. Loading was
carried out for 90 min at 30‡C. Then GAP activity was assayed in
a ¢nal volume of 10Wl in the presence of 5 mM MgCl2, 1mM DTT,
1 mM ATP plus the above mentioned ATP/GTP regeneration system,
25 mM MOPS bu¡er (pH 7.5), 0.5 mM unlabeled GTP, 0.1 unit/ml
guanylate kinase, and 1 Wl of [K-32P]GTP-loaded ARF. Considering
that ¢lter binding assays [23] showed that about 30^40% of the
[K-32P]GTP becomes associated with recombinant ARF1, free GTP
was removed from the reaction system after GAP3 digestion, i.e.
following incubation for 15 min at 30‡C, unbound GTP was removed
by centrifugation ¢ltration through nitrocellulose and rinsed ¢ve times
with 25 mM MOPS bu¡er (pH 7.5). The protein-bound nucleotides
were trapped on nitrocellulose ¢lters and then eluted from the ¢lters
in 2 M formic acid. ARF-bound GTP and GDP were separated by
thin layer chromatography on polyethyleneimine^cellulose plates in
1 M formic acid/1 M LiCl. [K-32P]GDP formation was determined
by autoradiography at 380‡C for 18^28 h. Data were presented as
the percentage of ARF-bound [K-32P]GTP that is converted to ARF-
bound [K-32P]GDP. GAP activity was assessed by serial dilutions of
the sample.
2.8. Secretion assay of SEAP
COS-7 cells grown in 6-well plates were co-transfected with pGEM-
SEAP and pcDNA3.1/myc-His-ARFGAP3 by the lipofectamine-
mediated method. At 12 h after transfection, the medium was
changed. 24, 36, and 48 h later, the culture supernatants were taken,
and the cells were lysed in ice-cold growth medium supplemented with
1% Triton X-100 and 1 mM PMSF, 10 Wl/ml of leupeptin, and 10
Wl/ml of aprotinin. SEAP activity in culture supernatants and in cell
lysates was determined by using Great EscAPe1 SEAP chemilumi-
nescence detection kit (Clontech). Secretion was expressed as the ratio
of SEAP activity in culture supernatants to the sum of SEAP activity
in both culture supernatants and cell lysates. All experiments were
performed in triplicate. The expression of pcDNA3.1/myc-His-ARF-
GAP3 constructs was veri¢ed by immunoblotting analysis.
3. Results
3.1. Subcellular localization of ARFGAP3
To determine the subcellular localization of ARFGAP3 in
eukaryotic cells, we tagged the N-terminus of ARFGAP3 with
GFP, expressed the fusion protein in cultured cells by trans-
fection, and examined the transfected cells under a epi£uo-
rescence microscope. The expression of GFP^ARFGAP3
was veri¢ed by Western blotting analysis using mouse mono-
clonal anti-GFP antibodies (Fig. 1A).
12 h after transfection, weak and di¡use £uorescence was
observed in the whole cytoplasm of COS-7 cells transfected
with pEGFP-C1-ARFGAP3 (Fig. 1B-b). 24 h after transfec-
tion, the £uorescence was restricted to the perinuclear region.
In some cells, the most prominent feature was an intense,
compact, well-delineated area of £uorescence adjacent to the
nucleus (Fig. 1B-c). 48 h after transfection, the £uorescence
was further concentrated in the perinuclear region (Fig. 4B-d).
In comparison, only weak and di¡use £uorescence was ob-
served in the whole COS-7 cells transfected with control plas-
mid pEGFP-C1 (Fig. 1B-a) at the same time. These results
showed that ARFGAP3 is a cytosolic protein and concen-
trated mainly in the perinuclear region.
3.2. Expression and puri¢cation of recombinant ARFGAP3
protein
The Thioredoxin^ARFGAP3 fusion protein was expressed
in TOP10 cells induced by arabinose (Fig. 2, lane 4), and
puri¢ed by a⁄nity chromatography on a nickel-chelating col-
umn (Fig. 2, lane 5) and cleaved by Enterokinase (Fig. 2, lane
6), then puri¢ed again on a nickel-chelating column (Fig. 2,
lane7). At last, the target protein ARFGAP3 was obtained at
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a purity of 90 percent with an identical molecular weight as
expected from its cDNA.
3.3. ARFGAP3 protein exhibits ARF GAP activity in vitro
The puri¢ed recombinant ARFGAP3 protein was tested in
vitro for ARF GAP activity by using ARF1 as substrate. As
shown in Fig. 3A, ARFGAP3 was unable to hydrolyze free
[K-32P]GTP, but led to hydrolysis of ARF-bound GTP in a
concentration-dependent manner (Fig. 3B), indicating that
ARFGAP3 acts as a GAP for ARF1. Furthermore, we also
determined the e¡ect of phospholipids upon GAP activity
exhibited by the recombinant ARFGAP3 and indicated that
the GAP activity of ARFGAP3 was enhanced by PIP2 (Fig.
3C), but decreased by PC (Fig. 3D).
3.4. Ectopic expression of ARFGAP3 reduces constitutive
secretion of protein in vivo
To determine whether ARFGAP3 regulates cellular secre-
tion in vivo we ectopically expressed ARFGAP3 in COS-7
cells. The expression of recombinant ARFGAP3 in COS-7
cells was con¢rmed by Western blotting analysis. The myc-
tagged ARFGAP3 was evidenced in lysates from COS-7 cells
transfected with expression vectors pcDNA3.1/myc-His-ARF-
GAP3 using mouse monoclonal anti-myc antibodies (Fig.
4A). Then, as shown in Fig. 4B, approximately 90% of the
total SEAP synthesized in mock-transfected cells was released
into the medium after 24 and 36 h. In contrast, ARFGAP3
signi¢cantly decreased SEAP secretion at 24 and 36 h after co-
transfection. At 48 h after co-transfection, the inhibitory ac-
tivity disappeared. As a control, co-transfection of exogenous
Lac Z with SEAP had no e¡ect on SEAP secretion of trans-
fected cells, suggesting that the inhibition e¡ect of ARFGAP3
on SEAP secretion may not due to the overexpression of non-
speci¢c exogenous protein(s). These results indicate that ARF-
GAP3 reduced constitutive secretion of target cells, suggesting
that ARFGAP3 may play a role in protein secretion of host
cells.
4. Discussion
ARFs are critical components of vesicular tra⁄cking path-
ways in eukaryotes, and the duration of their activity is con-
trolled by GAPs [2^4]. Recently, we reported a novel human
gene, ARFGAP3, which was deduced to be a new member of
ARF GAP family with a potential function in regulation of
cellular secretion [15]. Herein, the cellular localization and
functional characterization of ARFGAP3 was reported. It
was demonstrated that the puri¢ed recombinant ARFGAP3
exhibited strong GAP activity towards ARF1 protein. Ran-
dazzo and Kahn [20] reported that ARF GAP activity in a
partially puri¢ed preparation from bovine brain was modu-
lated by phospholipids. Among various phospholipids, PIP2
strongly stimulated GAP activity of some ARF GAPs; PC
caused a small but reproducible inhibition of ARF GAP ac-
tivity [8,10,12,20,24]. Like all the known ARFGAPs, ARF-
GAP3 displayed similar phospholipid sensitivity results. Thus,
it was evident that ARFGAP3 exhibited a typical activity of
ARF GAP.
Fig. 2. Expression, puri¢cation, and cleavage of thioredoxin^ARF-
GAP3 protein from E. coli cells. (1) Molecular weight markers;
(2) negative control: total cell proteins of TOP10 cell ; (3) positive
control: total cell proteins of TOP10 cell carrying pBAD-Thio in-
duced by arabinose; (4) total cell proteins of induced TOP10 cell
carrying pBAD/Thio^ARFGAP3; (5) puri¢ed recombinant fusion
protein Thio^ARFGAP3 (5 Wg); (6) puri¢ed recombinant fusion
protein cleaved by EKMax1 ; (7) target protein ARFGAP3 puri¢ed
again after cleavage by EKMax1 (5 Wg). These proteins were ana-
lyzed by electrophoresis on SDS^polyacrylamide gels, and stained
with Coomassie bright blue.
Fig. 1. Subcellular localization of ARFGAP3 tagged with GFP. A:
Western blotting analysis of the expressed recombinant fusion pro-
tein GFP^ARFGAP3. Lysates from COS-7 cells transfected with
pEGFP-C1, or pEGFP-C1-ARFGAP3 were subjected to immuno-
blotting with anti-GFP antibodies. Lysates from parent COS-7 cells
without transfection were used as negative control. B: Subcellular
localization of ARFGAP3 tagged with GFP. a: COS-7 cells trans-
fected with pEGFP-C1; b^d: COS-7 cells transfected with pEGFP-
C1-ARFGAP3 at 12, 24, or 48 h after transfection.
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To test the subcellular localization of ARFGAP3, we
tagged the N-terminus of ARFGAP3 with GFP, expressed
the fusion protein in cultured cells by transfection and ob-
served in living cells by epi£uorescence microscopy. It was
demonstrated that ARFGAP3 is a cytosolic protein and con-
centrated in the perinuclear region. The perinuclear region
contains many di¡erent organelles, including Golgi, the mi-
crotubule-organizing center, and vesicular structures of the
endosome^lysosome system [25]. It has been demonstrated
that ARF1 displays a typical Golgi localization, where
ARF1 exert its function of control of vesicular transport
[26]. Thus, it is reasonable to propose that ARFGAP3 may
be associated with the structures above and involved in the
regulation of vesicular transport.
ARF1 was implicated in the control of vesicle transport in
di¡erent intracellular compartments, including the Golgi com-
plex. In this study, transient ectopic expression of ARFGAP3
in cultured mammalian cells caused partial inhibition of the
constitutive secretion of SEAP. The result is quantitatively
similar with that of Pap, a new Pyk2 binding protein with
ARF GAP activity [12]. The inhibition implicated that ARF-
GAP3, like other known ARFGAPs, may exert ARF GAP
activity in these cells, and function in protein secretion or/and
vesicle transport.
Taken together, these results suggest that ARFGAP3 is a
novel member of ARF GAP family and might be involved in
the regulation of cellular secretion. So far, it remains to be
determined what is its exact physiological role, e.g. in endo-
crine glands and testis, and what is its speci¢city for di¡erent
ARFs. However, the characterization of biochemical function
of ARFGAP3 will advance our understanding of the regula-
tion of the cellular process in which ARF proteins participate,
especially in human. In addition, considering that ARFGAP3
was the ¢rst known member of ARFGAP family in human
beings and strongly expressed in endocrine glands and testis,
the knowledge about it might signi¢cantly facilitate the under-
Fig. 3. GAP activity of ARFGAP3 and its regulation by lipids. A: GAP activity of ARFGAP3 with substrate of recombinant ARF1: GAP ac-
tivity was assayed with 5 Wg/ml ARF1 plus 0 WM (1), 1.0 WM (2), 10 WM (3) ARFGAP3, or 10 WM ARFGAP3 with free GTP instead of
ARF-GTP (4). B^E: E¡ect of lipids on the GAP activity of ARFGAP3. GAP activity was assayed in the absence or presence of 100 WM PIP2
or 1.3 mM PC. The data are the average of two experiments.
FEBS 24584 2-2-01
X. Liu et al./FEBS Letters 490 (2001) 79^8382
standing of physiology and pathology of endocrine glands and
testis and their related diseases.
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Fig. 4. Inhibition of cellular SEAP secretion by overexpressed ARF-
GAP3 in vivo. A: Western blotting analysis of the expression of re-
combinant ARFGAP3 protein in COS-7 cells. Lysates from COS-7
cells transfected with expression vectors pcDNA3.1/myc-His A,
pcDNA3.1/myc-His-lacZ, pcDNA3.1/myc-His-ARFGAP3 respec-
tively, were subjected to immunoblotting with anti-myc antibodies.
B: Inhibition of cellular SEAP secretion by overexpression of ARF-
GAP3. Cells were co-transfected with expression vectors for SEAP
and for ARFGAP3. The graphs depict the amount of SEAP re-
leased into the medium as a percentage of the total SEAP ex-
pressed. All experiments were done in triplicate. Error bars repre-
sent standard deviation values.
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